Literature DB >> 27358407

Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver.

Tao Sun1, Haiqing Yi1, Chunyu Yang1, Priya S Kishnani1, Baodong Sun2.   

Abstract

A small portion of cellular glycogen is transported to and degraded in lysosomes by acid α-glucosidase (GAA) in mammals, but it is unclear why and how glycogen is transported to the lysosomes. Stbd1 has recently been proposed to participate in glycogen trafficking to lysosomes. However, our previous study demonstrated that knockdown of Stbd1 in GAA knock-out mice did not alter lysosomal glycogen storage in skeletal muscles. To further determine whether Stbd1 participates in glycogen transport to lysosomes, we generated GAA/Stbd1 double knock-out mice. In fasted double knock-out mice, glycogen accumulation in skeletal and cardiac muscles was not affected, but glycogen content in liver was reduced by nearly 73% at 3 months of age and by 60% at 13 months as compared with GAA knock-out mice, indicating that the transport of glycogen to lysosomes was suppressed in liver by the loss of Stbd1. Exogenous expression of human Stbd1 in double knock-out mice restored the liver lysosomal glycogen content to the level of GAA knock-out mice, as did a mutant lacking the Atg8 family interacting motif (AIM) and another mutant that contains only the N-terminal 24 hydrophobic segment and the C-terminal starch binding domain (CBM20) interlinked by an HA tag. Our results demonstrate that Stbd1 plays a dominant role in glycogen transport to lysosomes in liver and that the N-terminal transmembrane region and the C-terminal CBM20 domain are critical for this function.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Stbd1; glycogen; glycogen storage disease; liver; lysosome; transport

Mesh:

Substances:

Year:  2016        PMID: 27358407      PMCID: PMC4974364          DOI: 10.1074/jbc.C116.741397

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Glycogen and its metabolism: some new developments and old themes.

Authors:  Peter J Roach; Anna A Depaoli-Roach; Thomas D Hurley; Vincent S Tagliabracci
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

2.  Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience.

Authors:  Anupam Chakrapani; Ashok Vellodi; Peter Robinson; Simon Jones; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2010-09-24       Impact factor: 4.982

3.  High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa.

Authors:  Juna M de Vries; Nadine A M E van der Beek; Marian A Kroos; Lale Ozkan; Pieter A van Doorn; Susan M Richards; Crystal C C Sung; Jan-Dietert C Brugma; Adrienne A M Zandbergen; Ans T van der Ploeg; Arnold J J Reuser
Journal:  Mol Genet Metab       Date:  2010-08-14       Impact factor: 4.797

4.  Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: Identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1.

Authors:  Sixin Jiang; Clark D Wells; Peter J Roach
Journal:  Biochem Biophys Res Commun       Date:  2011-08-27       Impact factor: 3.575

5.  Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants.

Authors:  Priya S Kishnani; Paula C Goldenberg; Stephanie L DeArmey; James Heller; Danny Benjamin; Sarah Young; Deeksha Bali; Sue Ann Smith; Jennifer S Li; Hanna Mandel; Dwight Koeberl; Amy Rosenberg; Y-T Chen
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

6.  Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.

Authors:  Baodong Sun; Sarah P Young; Ping Li; Chunhui Di; Talmage Brown; Maja Z Salva; Songtao Li; Andrew Bird; Zhen Yan; Richard Auten; Stephen D Hauschka; Dwight D Koeberl
Journal:  Mol Ther       Date:  2008-06-17       Impact factor: 11.454

Review 7.  Pompe disease in infants and children.

Authors:  Priya Sunil Kishnani; R Rodney Howell
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

8.  Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation.

Authors:  Haiqing Yi; Keri B Fredrickson; Stuti Das; Priya S Kishnani; Baodong Sun
Journal:  Mol Genet Metab       Date:  2013-05-18       Impact factor: 4.797

9.  Expression of gec1/GABARAPL1 versus GABARAP mRNAs in human: predominance of gec1/GABARAPL1 in the central nervous system.

Authors:  Christophe Nemos; Virginie Mansuy; Sandrine Vernier-Magnin; Annick Fraichard; Michèle Jouvenot; Régis Delage-Mourroux
Journal:  Brain Res Mol Brain Res       Date:  2003-11-26

10.  The carbohydrate-binding domain of overexpressed STBD1 is important for its stability and protein-protein interactions.

Authors:  Yuanqi Zhu; Mei Zhang; Amber Renee Kelly; Alan Cheng
Journal:  Biosci Rep       Date:  2014-07-01       Impact factor: 3.840

View more
  10 in total

Review 1.  Pros and cons of different ways to address dysfunctional autophagy in Pompe disease.

Authors:  Jeong-A Lim; Naresh Kumar Meena; Nina Raben
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  Autophagy in the liver: functions in health and disease.

Authors:  Takashi Ueno; Masaaki Komatsu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

3.  Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.

Authors:  Yang Cheng; Jian Ping; Jianjie Chen
Journal:  Pathol Oncol Res       Date:  2017-07-01       Impact factor: 3.201

Review 4.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

5.  Characterization of the Skeletal Muscle Proteome in Undernourished Old Rats.

Authors:  Caroline Barbé; Jérôme Salles; Christophe Chambon; Christophe Giraudet; Phelipe Sanchez; Véronique Patrac; Philippe Denis; Yves Boirie; Stéphane Walrand; Marine Gueugneau
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

Review 6.  Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.

Authors:  M Kathryn Brewer; Matthew S Gentry
Journal:  Adv Neurobiol       Date:  2019

7.  Mouse Stbd1 is N-myristoylated and affects ER-mitochondria association and mitochondrial morphology.

Authors:  Anthi Demetriadou; Julia Morales-Sanfrutos; Marianna Nearchou; Otto Baba; Kyriacos Kyriacou; Edward W Tate; Anthi Drousiotou; Petros P Petrou
Journal:  J Cell Sci       Date:  2017-01-30       Impact factor: 5.285

8.  Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels.

Authors:  Takuya Kuno; Mio Hirayama-Kurogi; Shingo Ito; Sumio Ohtsuki
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

Review 9.  Therapeutic regulation of autophagy in hepatic metabolism.

Authors:  Katherine Byrnes; Sophia Blessinger; Niani Tiaye Bailey; Russell Scaife; Gang Liu; Bilon Khambu
Journal:  Acta Pharm Sin B       Date:  2021-07-28       Impact factor: 11.413

10.  Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism.

Authors:  Christoph Metzendorf; Katharina Wineberger; Jenny Rausch; Antonio Cigliano; Kristin Peters; Baodong Sun; Daniela Mennerich; Thomas Kietzmann; Diego F Calvisi; Frank Dombrowski; Silvia Ribback
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.